Review and consensus on pharmacogenomic testing in psychiatry

CA Bousman, SA Bengesser, KJ Aitchison… - …, 2021 - thieme-connect.com
The implementation of pharmacogenomic (PGx) testing in psychiatry remains modest, in part
due to divergent perceptions of the quality and completeness of the evidence base and …

Nicotine replacement therapy versus control for smoking cessation

J Hartmann‐Boyce, SC Chepkin, W Ye… - Cochrane database …, 2018 - cochranelibrary.com
Background Nicotine replacement therapy (NRT) aims to temporarily replace much of the
nicotine from cigarettes to reduce motivation to smoke and nicotine withdrawal symptoms …

Initiating pharmacologic treatment in tobacco-dependent adults. An official American Thoracic Society clinical practice guideline

FT Leone, Y Zhang, S Evers-Casey… - American journal of …, 2020 - atsjournals.org
Background: Current tobacco treatment guidelines have established the efficacy of available
interventions, but they do not provide detailed guidance for common implementation …

Precision medicine—personalized, problematic, and promising

JL Jameson, DL Longo - Obstetrical & gynecological survey, 2015 - journals.lww.com
Precision medicine is a term used to describe individualized treatment that encompasses
the use of new diagnostics and therapeutics, targeted to the needs of a patient based on …

Current advances in research in treatment and recovery: Nicotine addiction

JJ Prochaska, NL Benowitz - Science advances, 2019 - science.org
The health harms of combusted tobacco use are undeniable. With market and regulatory
pressures to reduce the harms of nicotine delivery by combustion, the tobacco product …

The neurobiology of addiction

GR Uhl, GF Koob, J Cable - Annals of the New York Academy …, 2019 - Wiley Online Library
Substance and alcohol use disorders impose large health and economic burdens on
individuals, families, communities, and society. Neither prevention nor treatment efforts are …

Precision medicine from a public health perspective

R Ramaswami, R Bayer, S Galea - Annual review of public …, 2018 - annualreviews.org
Over the past decade, precision medicine (PM) approaches have received significant
investment to create new therapies, learn more about disease processes, and potentially …

Variation in CYP2A6 activity and personalized medicine

JA Tanner, RF Tyndale - Journal of personalized medicine, 2017 - mdpi.com
The cytochrome P450 2A6 (CYP2A6) enzyme metabolizes several clinically relevant
substrates, including nicotine—the primary psychoactive component in cigarette smoke. The …

The past, present, and future of nicotine addiction therapy

JJ Prochaska, NL Benowitz - Annual review of medicine, 2016 - annualreviews.org
The tobacco addiction treatment field is progressing through innovations in medication
development, a focus on precision medicine, and application of new technologies for …

Tobacco addiction

P Selby, L Zawertailo - New England Journal of Medicine, 2022 - Mass Medical Soc
Key Clinical Points Tobacco Addiction Tobacco addiction is a chronic relapsing disorder that
accounts for more than 480,000 deaths annually in the United States and is characterized by …